| Dr Valerie A Knudsen, MD | |
|
2831 Fort Missoula Rd, Suite 306, Missoula, MT 59804-7419 | |
| (406) 327-4395 | |
| (406) 327-4394 |
| Full Name | Dr Valerie A Knudsen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 2831 Fort Missoula Rd, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194704437 | NPI | - | NPPES |
| 0021863 | Medicaid | ID | |
| 81054459959804A001 | Other | WPS TRICARE | |
| 0042245 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5310 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Valerie A Knudsen, MD Po Box 1130, Helena, MT 59624-1130 Ph: (406) 443-3076 | Dr Valerie A Knudsen, MD 2831 Fort Missoula Rd, Suite 306, Missoula, MT 59804-7419 Ph: (406) 327-4395 |
News Archive
Alcon, Inc. reported that global sales rose 12.5 percent to $1.89 billion for the second quarter of 2010, or 11.3 percent excluding the impact of foreign exchange fluctuations and acquisitions. Revenue from acquisitions added 40 basis points to sales growth in the quarter, while foreign currency fluctuations added 80 basis points of growth.
Award-winning neurologist Dr. Shelagh Coutts is on the fast track of developing new brain scanning techniques for rapid and effective diagnosis of mini-strokes.
Isogenica Ltd today announced that it has entered into an agreement with Australian based biopharmaceutical company Phylogica to use Isogenica's CIS display technology to optimize the performance of three of Phylogica's lead compounds targeting CD40 ligand (CD40L). CD40L is a key protein involved in many inflammatory diseases, such as Rheumatoid Arthritis and Inflammatory Bowel Disease.
A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found.
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
› Verified 8 days ago
Amethyst Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-329-7103 | |
Dr. Kristin Ann Rauch, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2825 Fort Missoula Rd, #115, Missoula, MT 59804 Phone: 406-728-4292 Fax: 406-728-5770 | |
Dr. Dionne Drakulich, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2835 Fort Missoula Rd Ste 101, Missoula, MT 59804 Phone: 406-327-4640 Fax: 504-988-1846 | |
Jennifer Larson, ARNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3624 Brooks St Ste 101, Missoula, MT 59801 Phone: 888-227-3312 | |
Jesse J Pitt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2825 Fort Missoula Road, Suite 225, Missoula, MT 59804 Phone: 406-721-1640 Fax: 406-721-2138 | |
Dr. Gregory O Utter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Community Medical Center Physician Building 3, 2835 Fort Missoula Rd. Suite 304, Missoula, MT 59804 Phone: 406-327-3924 Fax: 406-327-3923 |